Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Reduced matriptase activity causes skin and hair issues in both humans and mice.

Netherton syndrome causes skin and hair issues, confirmed by "bamboo hair" under dermoscopy, with no cure but managed with topical treatments.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Narrowband UVB therapy significantly improved a child's rare skin condition.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

ZPK helps skin cells mature and may affect skin health.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

Cepharanthine shows promise as a COVID-19 treatment.

Oral Acitretin effectively resolved symptoms in a child with Netherton syndrome.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Cholesterol helps hair grow by activating nerves and boosting hair follicle stem cells.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

MMP-19 may worsen skin diseases by affecting skin growth and inflammation.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.